1. Avissar S, Schreiber G (1989) Muscarinic receptor subclassification and G-proteins; significance for lithium action in affective disorders and for the treatment of the extrapyramidal side effects of neuroleptics. Biol Psychiatry 26: 113–130
2. Birdsall NJM, Hulme EC, Kromer W, Peck BS, Stockron JM, Zigmond MJ (1987) Two drug binding sites on muscarinic receptors. In: Briley M, Kato A, Weber M (eds) New concepts in Alzheimer’s disease. MacMillan, London New York, pp 103–121
3. Brann MR, Buckley NJ, Bonner TI (1988) The striatum and cerebral cortex express different muscarine receptor MRNAS. FEBS Lett 230: 90–94
4. Burke RE, Fahn S (1982) Pharmacokinetics of trihexyphenidyl after acute and chronic administration. Ann Neurol 12: 94
5. Dale HH (1914) The action of certain esters and ethers of choline and their relation to muscarine. J Pharmacol Exp Ther 6: 147–190